南京医药
(600713)
| 流通市值：67.72亿 | | | 总市值：68.68亿 |
| 流通股本：12.90亿 | | | 总股本：13.08亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,879,489,023 | 2,947,076,026.35 | 2,052,357,616.98 | 3,049,215,267.9 |
| 交易性金融资产 | 125,232,438.81 | 140,255,452.06 | 170,199,024.66 | 215,282,526.03 |
| 应收票据及应收账款 | 19,333,151,443.99 | 17,738,201,215.94 | 16,851,787,748.61 | 13,044,039,244.53 |
| 其中：应收票据 | 624,063,819.37 | 310,970,379.29 | 268,781,092.3 | 197,296,918.82 |
| 应收账款 | 18,709,087,624.62 | 17,427,230,836.65 | 16,583,006,656.31 | 12,846,742,325.71 |
| 应收款项融资 | 4,374,660,639.78 | 3,455,340,710.31 | 4,235,180,141.41 | 3,244,901,107.11 |
| 预付款项 | 1,116,082,536.64 | 1,166,957,629.12 | 1,032,136,998.85 | 975,010,006.81 |
| 其他应收款合计 | 811,483,014.9 | 852,131,504.73 | 877,129,976.03 | 818,207,831.58 |
| 存货 | 7,237,922,954.13 | 6,837,988,946.15 | 7,098,028,073.01 | 6,903,988,329.82 |
| 一年内到期的非流动资产 | 20,000,000 | - | - | - |
| 其他流动资产 | 76,216,750.28 | 111,204,074.33 | 148,381,418 | 161,097,090.66 |
| 流动资产合计 | 34,974,238,801.53 | 33,249,155,558.99 | 32,465,200,997.55 | 28,411,741,404.44 |
| 非流动资产: | | | | |
| 长期股权投资 | 99,688,544.58 | 90,996,290.72 | 89,779,418.5 | 73,795,818.67 |
| 其他权益工具投资 | 166,525,902.94 | 163,600,522.29 | 181,527,951.69 | 195,444,910.04 |
| 其他非流动金融资产 | 20,000,000 | - | - | - |
| 投资性房地产 | 103,313,296.61 | 99,963,354.74 | 102,645,162.84 | 101,143,591.61 |
| 固定资产 | 1,588,181,466.92 | 1,575,952,358.01 | 1,340,124,627.59 | 1,353,117,053.87 |
| 在建工程 | 168,534,894.41 | 169,775,006.59 | 374,296,992.57 | 349,685,556.36 |
| 使用权资产 | 275,824,431.59 | 283,831,953.68 | 294,297,901.92 | 301,173,663.71 |
| 无形资产 | 314,497,057.01 | 217,542,913.52 | 200,354,501.14 | 209,492,679.05 |
| 开发支出 | 76,153,560.05 | 75,189,972.34 | 63,632,382.19 | 50,409,079.26 |
| 商誉 | 263,786,174.25 | 63,244,637.68 | 63,244,637.68 | 63,244,637.68 |
| 长期待摊费用 | 58,279,512.59 | 44,519,484.22 | 45,122,392.8 | 47,853,550.02 |
| 递延所得税资产 | 309,197,090.71 | 294,143,220 | 282,680,768.95 | 271,265,746.46 |
| 其他非流动资产 | 245,461,120.83 | 1,255,195.04 | 1,568,525.8 | 2,038,119.2 |
| 非流动资产合计 | 3,689,443,052.49 | 3,080,014,908.83 | 3,039,275,263.67 | 3,018,664,405.93 |
| 资产总计 | 38,663,681,854.02 | 36,329,170,467.82 | 35,504,476,261.22 | 31,430,405,810.37 |
| 流动负债: | | | | |
| 短期借款 | 3,871,882,817.27 | 4,854,868,702.41 | 4,973,611,619.13 | 1,220,364,283.47 |
| 应付票据及应付账款 | 10,910,980,021.9 | 10,816,508,097.53 | 10,704,337,566.35 | 11,097,906,935.13 |
| 其中：应付票据 | 2,851,547,309.43 | 3,205,168,773.28 | 3,211,719,039.65 | 2,945,841,436.1 |
| 应付账款 | 8,059,432,712.47 | 7,611,339,324.25 | 7,492,618,526.7 | 8,152,065,499.03 |
| 合同负债 | 300,978,102.8 | 258,934,658.11 | 306,741,086.17 | 333,993,017.78 |
| 应付职工薪酬 | 131,871,032.46 | 118,382,096.89 | 139,213,253.44 | 212,823,515.12 |
| 应交税费 | 197,080,901.32 | 173,132,362.04 | 236,975,796.59 | 297,117,810.67 |
| 其他应付款合计 | 2,636,440,739.47 | 1,982,090,053.27 | 2,168,832,543.56 | 1,956,140,147.31 |
| 一年内到期的非流动负债 | 83,728,821.56 | 91,525,403.92 | 287,800,833.83 | 278,022,664.59 |
| 其他流动负债 | 6,128,888,537.96 | 4,605,077,880.74 | 3,613,459,877.34 | 3,124,086,320.26 |
| 流动负债合计 | 24,261,850,974.74 | 22,900,519,254.91 | 22,430,972,576.41 | 18,520,454,694.33 |
| 非流动负债: | | | | |
| 应付债券 | 5,150,291,885.99 | 4,641,404,798.05 | 4,112,987,911.17 | 4,146,165,413.63 |
| 租赁负债 | 181,585,604.98 | 178,428,531.17 | 176,755,190.52 | 192,066,801.91 |
| 递延收益 | 255,274,866.96 | 256,350,606.3 | 266,098,440.43 | 260,787,100.23 |
| 递延所得税负债 | 55,993,991.82 | 48,793,042.96 | 54,296,088.92 | 58,041,433.79 |
| 非流动负债合计 | 5,643,146,349.75 | 5,124,976,978.48 | 4,610,137,631.04 | 4,657,060,749.56 |
| 负债合计 | 29,904,997,324.49 | 28,025,496,233.39 | 27,041,110,207.45 | 23,177,515,443.89 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,308,164,641 | 1,308,164,032 | 1,308,892,948 | 1,308,931,630 |
| 其他权益工具 | 6,677,239.77 | 6,677,258.37 | 6,677,599.37 | 6,677,636.57 |
| 资本公积 | 2,464,284,794.12 | 2,460,251,436.18 | 2,457,563,977 | 2,453,950,805.17 |
| 减:库存股 | 37,540,400.48 | 39,191,929.28 | 43,706,552 | 51,325,807.68 |
| 其他综合收益 | 66,602,177.88 | 71,920,637.58 | 78,581,501.03 | 91,817,977.93 |
| 盈余公积 | 361,600,386.25 | 361,600,386.25 | 361,600,386.25 | 361,600,386.25 |
| 未分配利润 | 3,088,499,453.12 | 3,085,485,394.16 | 3,187,971,623.21 | 3,013,402,037.71 |
| 归属于母公司股东权益合计 | 7,258,288,291.66 | 7,254,907,215.26 | 7,357,581,482.86 | 7,185,054,665.95 |
| 少数股东权益 | 1,500,396,237.87 | 1,048,767,019.17 | 1,105,784,570.91 | 1,067,835,700.53 |
| 股东权益合计 | 8,758,684,529.53 | 8,303,674,234.43 | 8,463,366,053.77 | 8,252,890,366.48 |
| 负债和股东权益合计 | 38,663,681,854.02 | 36,329,170,467.82 | 35,504,476,261.22 | 31,430,405,810.37 |
| 公告日期 | 2026-10-31 | 2026-08-29 | 2026-04-30 | 2026-04-11 |
| 审计意见(境内) | | | | 标准无保留意见 |